Therefore, downregulating NF-κB activation, which is involved in a wide range of cellular activities including regulation of inflammatory responses, immune regulation, and apoptosis, may prevent NASH development. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.